5 completed, 1 terminated, 1 unknown. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Terminated 1, Unknown 1 |
Follow nepafenac: new trials by email Literature Review of nepafenac trials Research Report on nepafenac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops Nepafenac 0.1% Oph Susp, Refresh Tears 0.5% Lubricant Eye Drops - Congenital Hereditary Endothelial Dystrophy of Cornea | Phase 2 | Unknown | L.V. Prasad Eye Institute | 30 | 2020-12-15 | 2021-04-14 |
| Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification PRO-155, Nevanac - Cataract, Phacoemulsification Cataract Surgery | Phase 2 | Completed | Laboratorios Sophia S.A de C.V. | 160 | 2013-12-01 | 2018-10-30 |
| NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) nepafenac 0.1% drops, Nepafenac Vehicle - Diabetic Macular Edema | Phase 2 | Completed | Jaeb Center for Health Research | 125 | 2011-05-01 | 2025-03-10 |
| Nepafenac 0.3% Two Study Nepafenac Ophthalmic Suspension, 0.3%, Nepafenac Ophthalmic Suspension, 0.1%, Nepafenac Vehicle 0.3% - Cataract | Phase 2 | Completed | Alcon Research | 1342 | 2011-03-01 | 2012-12-17 |
| A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients Nepafenac ophthalmic suspension, 0.1% (NEVANAC), Nepafenac ophthalmic suspension vehicle, Prednisolone acetate ophthalmic suspension (OMNIPRED) - Macular Edema | Phase 2 | Completed | Alcon Research | 263 | 2008-11-01 | 2012-10-26 |
| Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation Nepafenac, Lubricant - Macular Thickening, Macular Edema | Phase 2 | Terminated | Asociación para Evitar la Ceguera en México | 50 | 2008-08-01 | 2024-05-30 |
| Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema Ketorolac, Nepafenac, Polietilenglicol 400, propilenglicol - Diabetic Retinopathy, Macular Edema | Phase 2 | Completed | Hospital Juarez de Mexico | 84 | 2008-04-01 | 2015-03-20 |
Macular Edema (4) · Cataract (2) · Diabetic Retinopathy (2) · Corneal Dystrophy, Posterior Polymorphous, 1 (1) · Inflammation (1) · Pain (1)
Alcon Research (2) · Asociación para Evitar la Ceguera en México (1) · Hospital Juarez de Mexico (1) · Jaeb Center for Health Research (1) · L.V. Prasad Eye Institute (1) · Laboratorios Sophia S.A de C.V. (1)
Mexico (3) · United States (2) · India (1)
Dulce O Rascon-Vargas, Fellow (1) · Guadalupe Cervantes-Coste (1) · Jans Fromow-Guerra (1) · Juan Asbun Bojalil, MD, PhD (1) · Muralidhar Ramappa, MS (1) · Neet Y Mehta, MBBS (1) · Scott M Friedman, MD (1) · Virgilio Lima Gomez, MD, MSc (1)
PMID 22927737, PMID 25602634, PMID 27388251
U10EY014231 (1), U10EY018817 (1)